Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
Status:
Completed
Trial end date:
2020-12-27
Target enrollment:
Participant gender:
Summary
This is a Phase 1, 2-part, open-label study. Part A will be a formulation bridging and food
effect study in healthy adult subjects. Part B will be an assessment of pharmacokinetics (PK)
in healthy adult Chinese subjects.